Syros Pharmaceuticals (SYRS) Earnings Date, Estimates & Call Transcripts → You need to know these two things about AI stocks ASAP… (From InvestorPlace) (Ad) Free SYRS Stock Alerts $5.03 +0.02 (+0.40%) (As of 09:30 AM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 14Before Market OpensConfirmedActual EPS (Mar. 27) -$1.19 Beat By $0.04 Consensus EPS (Mar. 27) -$1.23 Get Syros Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for SYRS and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueSYRS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SYRS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaThe Crypto 9-5 Escape PlanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide Syros Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20243($1.20)($0.74)($0.98)Q2 20243($1.21)($0.77)($0.99)Q3 20243($1.17)($0.71)($0.88)Q4 20243($1.18)($0.71)($0.96)FY 202412($4.76)($2.93)($3.81)SYRS Earnings Date and InformationSyros Pharmaceuticals last released its quarterly earnings results on March 27th, 2024. The reported ($1.19) EPS for the quarter, beating the consensus estimate of ($1.23) by $0.04. The firm earned $0.39 million during the quarter, compared to the consensus estimate of $2.40 million. Syros Pharmaceuticals has generated ($5.76) earnings per share over the last year (($5.76) diluted earnings per share). Earnings for Syros Pharmaceuticals are expected to grow in the coming year, from ($3.78) to ($3.30) per share. Syros Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Tuesday, May 14th, 2024. Syros Pharmaceuticals will be holding an earnings conference call on Tuesday, May 14th at 8:30 AM Eastern. Interested parties can register for or listen to the call.. Read More Syros Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/14/2024Confirmed)------- 3/27/2024Q4 2023($1.23)($1.19)+$0.04($0.20)$2.40 million$0.39 million11/14/2023Q3 2023($1.12)($1.35)($0.23)($1.27)$3.90 million$3.76 million8/8/2023Q2 2023($1.11)($1.30)($0.19)($1.30)$3.17 million$2.83 million5/10/2023Q1 2023($1.12)($0.85)+$0.27($0.85)$2.95 million$2.95 million3/2/2023Q4 2022($1.27)($1.28)($0.01)($2.39)$3.28 million($0.75) million 11/14/2022Q3 2022($3.91)($2.41)+$1.50($1.61)$4.97 million$3.89 million Get the Latest News and Ratings for SYRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Syros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/9/2022Q2 2022($4.20)($5.40)($1.20)($0.54)$4.68 million$6.28 million5/16/2022Q1 2022($4.80)($4.00)+$0.80($0.40)$4.56 million$5.47 million 3/15/2022Q4 2021($4.40)($4.20)+$0.20($0.46)$5.65 million$7.80 million 11/5/2021Q3 2021($4.40)($4.10)+$0.30($0.41)$5.10 million$5.70 million 8/5/2021Q2 2021($3.60)($3.60)-($0.36)$4.58 million$5.16 million Syros Pharmaceuticals Earnings - Frequently Asked Questions When is Syros Pharmaceuticals's earnings date? Syros Pharmaceuticals has confirmed that its next quarterly earnings data will be published on Tuesday, May 14th, 2024. Learn more on SYRS's earnings history. Did Syros Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Syros Pharmaceuticals (NASDAQ:SYRS) reported ($1.19) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.23) by $0.04. Learn more on analysts' earnings estimate vs. SYRS's actual earnings. How much revenue does Syros Pharmaceuticals generate each year? Syros Pharmaceuticals (NASDAQ:SYRS) has a recorded annual revenue of $9.94 million. How much profit does Syros Pharmaceuticals generate each year? Syros Pharmaceuticals (NASDAQ:SYRS) has a recorded net income of -$164.57 million. SYRS has generated -$5.76 earnings per share over the last four quarters. What is Syros Pharmaceuticals's EPS forecast for next year? Syros Pharmaceuticals's earnings are expected to grow from ($3.78) per share to ($3.30) per share in the next year. More Earnings Resources from MarketBeat Related Companies: AEON Earnings MCRB Earnings CRVO Earnings RGLS Earnings INCR Earnings COYA Earnings PRQR Earnings VTGN Earnings SKYE Earnings GLSI Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:SYRS) was last updated on 5/10/2024 by MarketBeat.com Staff From Our Partners[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICYou need to know these two things about AI stocks ASAP…InvestorPlaceThis 1 Biotech Stock has been shocking the marketsHuge AlertsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward PressCharles Payne Demystifies OptionsUnstoppable Prosperity[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsBiden Nomination CANCELED?The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syros Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.